Total value in 2020: $4,712.83M (120 completed)

Company Location Gross (US$M) Round

March - $2,311.38M

Abbisko Therapeutics Co. Ltd. Shanghai $70.00 Series C
Advanced Biodesign SAS Lyon, France $9.80 N/A
Affinia Therapeutics Inc. Waltham, Mass. $60.00 Series A
Akouos Inc. Boston $105.00 Series B
AM-Pharma BV Utrecht, the Netherlands $25.50 Equity investment
AM-Pharma BV Utrecht, the Netherlands $26.50 Loan
Amunix Pharmaceuticals Inc. Mountain View, Calif. $73.00 Series A
Apexigen Inc. San Carlos, Calif. $65.00 Equity financing
Biosight Ltd. Airport City, Israel $19.00 Series C
Castle Creek Biosciences Inc. Exton, Pa. $75.00 N/A
Cinclus Pharma Holding AB Stockholm $26.30 N/A
Circle Pharma Inc. South San Francisco $45.00 Series B
Clarus Therapeutics Inc. Northbrook, Ill. $75.00 Debt financing
Design Therapeutics Inc. San Diego $45.00 Series A
Elevatebio LLC Cambridge, Mass. $170.00 Series B
Eureka Therapeutics Inc. Emeryville, Calif. $45.00 Series E
Evonetix Ltd. Cambridge, U.K. $30.00 Series B
Exuma Biotech Corp. West Palm Beach, Fla. $19.00 Series B
Harbour Biomed Therapeutics Ltd. Cambridge, Mass. $75.00 Series B
Immunocore Ltd. Abingdon, U.K. $130.00 Series B
Kallyope Inc. New York $112.00 Series C
Keros Therapeutics Inc. Lexington, Mass. $56.00 Series C
Kymera Therapeutics Inc. Cambridge, Mass. $102.00 Series C
Lipidio Pharmaceuticals Inc. San Diego N/A Series A
Nanjing Iaso Biotherapeutics Co. Ltd. Nanjing, China $60.00 Series B
Numab Therapeutics AG Waedenswil, Switzerland $23.80 Series B
Nurix Therapeutics Inc. San Francisco $120.00 N/A
Oncoone Research & Development GmbH Klosterneuburg, Austria $14.10 Series A
Onethree Biotech Inc. New York $2.50 Seed
Pliant Therapeutics Inc. South San Francisco $100.00 Series C
Polyprox Therapeutics Ltd. Cambridge, U.K. $1.28 Seed
Primmune Therapeutics Inc. San Diego $7.00 Seed
Recode Therapeutics Inc. Menlo Park, Calif. and Dallas $80.00 Series A
Redpin Therapeutics Inc. New York $15.50 Series A
Regenacy Pharmaceuticals Inc. Waltham, Mass. $30.00 Series A
Sigilon Inc. Cambridge, Mass. $80.30 Series B
Silverback Therapeutics Inc. Seattle $78.50 Series B
Sutrovax Inc. Foster City, Calif. $110.00 Series D
Svenska Vaccinfabriken Produktion AB Stockholm N/A N/A
Syndivia SAS Strasbourg, France $2.30 N/A
Tikomed AB Viken, Sweden $5.50 N/A
Xilio Therapeutics Inc. Waltham, Mass. $100.50 Series B
Zucara Therapeutics Inc. Toronto $21.00 Series A

No Comments